# Sutimlimab (Genetical Recombination) I.V. Infusion 1.1g (エジャイモ点滴静注１．１ｇ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 6399431A1023). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 6399431A1023
- **Product name (Japanese):** エジャイモ点滴静注１．１ｇ
- **English title:** Sutimlimab (Genetical Recombination) I.V. Infusion 1.1g
- **Active ingredient:** スチムリマブ（遺伝子組換え）
- **Active ingredient (INN):** Sutimlimab (Genetical Recombination)
- **Strength / unit:** １．１ｇ２２ｍＬ１瓶
- **Route:** Injection (注射薬)
- **Therapeutic category:** 63 Biological products (生物学的製剤) › 639 Other biological products (その他の生物学的製剤)
- **Manufacturer:** Recordati Rare Diseases Japan (レコルダティ・レア・ディジーズ・ジャパン)
- **NHI price (reference only):** JPY 244074 per １．１ｇ２２ｍＬ１瓶
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/6399431A1023
- **JSON:** https://www.nifujipharma.com/api/drugs/6399431A1023

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Sutimlimab%20(Genetical%20Recombination)%20I.V.%20Infusion%201.1g%20(%E3%82%A8%E3%82%B8%E3%83%A3%E3%82%A4%E3%83%A2%E7%82%B9%E6%BB%B4%E9%9D%99%E6%B3%A8%EF%BC%91%EF%BC%8E%EF%BC%91%EF%BD%87)%20%2F%20YJ%206399431A1023#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.